Journal of Pathology Clinical Research

Papers
(The median citation count of Journal of Pathology Clinical Research is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Issue Information76
Immune checkpoint CD161/LLT1‐associated immunological landscape and diagnostic value in oral squamous cell carcinoma46
Clinicopathological features and cancer transcriptomic profiling of poorly cohesive gastric carcinoma subtypes30
Clinical and molecular correlates of digitally quantified anthracosis in lung tissue slides: utility of an automated quantitative workflow29
A novel telomere biology disease‐associated gastritis identified through a whole exome sequencing‐driven approach28
The prognostic marker elastin correlates with epithelial–mesenchymal transition and vimentin‐positive fibroblasts in gastric cancer25
Diffuse glioma with FGFR3‐TACC3 fusion in adults is not a homogenous clinicopathological and molecular entity24
Gastric cancer immune microenvironment score predicts neoadjuvant chemotherapy efficacy and prognosis24
Leveraging deep learning to discover interpretable cellular spatial biomarkers for prognostic predictions based on hepatocellular carcinoma histology24
Issue Information23
Translational practice of fluorescence in situ hybridisation to identify neuroblastic tumours with TERT rearrangements22
SOX10 distinguishes oligodendrogliomas from low‐grade glioneuronal tumors/low‐grade gliomas with oligodendrocyte‐like features21
KLF2 inhibits colorectal cancer progression and metastasis by inducing ferroptosis via the PI3K/AKT signaling pathway21
MET ‐amplified gastric cancers exhibit co‐amplifications of BRAF20
Authors' reply: Re: Koga et al. Retrieval‐augmented generation versus document‐grounded generation: a key distinction in large language models19
19
Somatic whole exome sequencing of colorectal carcinoma in young patients from sub‐Saharan Africa reveals novel insights18
17
Cancer‐associated fibroblast expression of glutamine fructose‐6‐phosphate aminotransferase 2 (GFPT2) is a prognostic marker in gastric cancer16
MET fusions and splicing variants in glioma: a landscape integrating clinical, pathological, and survival features16
Authors' reply: Re: Yang et al . The road to therapy for myeloid sarcoma: navigating the complexities of subclonal MAPK 16
Validation of the prognostic value of CD3 and CD8 cell densities analogous to the Immunoscore® by stage and location of colorectal cancer: an independent patient cohort study14
Aberrant PRDM2 methylation as an early event in serrated lesions destined to evolve into microsatellite‐instable colorectal cancers14
KRAS mutations and endometriosis burden of disease13
Immune checkpoint profiling of B7 ‐H proteins predicts survival and treatment response in metastatic clear cell renal cell carcinoma13
Altered cytoplasmic and nuclear ADP‐ribosylation levels analyzed with an improved ADP‐ribose binder are a prognostic factor in renal cell carcinoma12
11
Validation of fibroblast activation protein and α‐smooth muscle actin as prognostic biomarkers in prostate cancer through AI ‐assisted image analysis11
Myeloid sarcoma shows a high frequency of mutations activating the MAPK/ERK pathway and association with clonal hematopoiesis11
Dual epigenetic changes in diabetes mellitus‐associated pancreatic ductal adenocarcinoma correlate with downregulation of E‐cadherin and worsened prognosis11
Real‐life data from standardized preanalytical coding (SPREC) in tissue biobanking and its dual use for sample characterization and process optimization10
Issue Information10
Engineering the future of 3D pathology10
Issue Information10
Issue Information10
10
Low‐burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation10
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study9
Cancer‐associated fibroblasts are associated with CD8 + T cell depletion and poor prognosis in colorectal adenocarcinoma: a multi‐omics and machine l9
Cell‐by‐cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression9
Validation of a whole slide image management system for metabolic‐associated steatohepatitis for clinical trials9
ATM immunohistochemistry as an effective screening method for POLE 9
Clinicopathologic and molecular landscape of villitis of unknown etiology: insights from a large‐scale case–control study in PR China9
Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancer8
pTDP‐43 aggregates accumulate in non‐central nervous system tissues prior to symptom onset in amyotrophic lateral sclerosis: a case series linking archival surgical biopsies with clinical p8
Issue Information8
Prognostic significance of beta‐adrenergic receptor expression in oesophageal adenocarcinoma8
A prognostic six‐gene expression risk‐score derived from proteomic profiling of the metastatic colorectal cancer secretome8
8
Oestrogen receptor phosphorylation profiles and in silico PAM50 subtyping reflect sexual dimorphism in breast cancer8
Exosome‐derived ANXA9 functions as an oncogene in breast cancer7
Folate receptor alpha ( FRα ) expression in tubo‐ovarian and endometrial tumors: a study of 923 cases7
First proficiency testing for NGS‐based and combined NGS‐ and FISH‐based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma7
Preservation of cell‐free RNA in percutaneous core‐needle biopsy specimens' supernatants from non‐small cell lung cancer improves genomic testing per7
Tumor‐type–specific expression of TTF ‐1 in primary central nervous system tumors classified by the 2021 WHO 7
Inter‐rater agreement of HER2 ‐low scores between expert breast pathologists and the Visiopharm digital image analysis application ( 7
MMR deficiency is frequent in colorectal carcinomas with diffuse SLFN11 immunostaining: clinicopathologic and molecular study of 31 cases identified among 3,300 tumors7
Weakly supervised deep learning for cutaneous squamous and basal cell carcinoma in whole‐slide histopathology7
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR‐mutated lung cancer treated with the first‐/second‐generation tyrosine kinase inhibitors6
Hyaluronan accumulation is associated with reduced hyaluronidase expression in renal cell carcinoma, with CD44, HAS1, and HYAL2 emerging as prognostic markers6
HISTAI : a valuable dataset with a valuable lesson6
Sarcomatoid areas of urothelial carcinoma are enriched for CD163‐positive antigen‐presenting cells6
Oncocytic and spindle cell typical carcinoids of lung: different immunophenotype and biological behavior6
Reduced GATA3 expression associates with immuno‐metabolic alterations and aggressive features in breast cancer6
Closing the loop – the role of pathologists in digital and computational pathology research6
DNA methylation profile discriminates sporadic giant cell granulomas of the jaws and cherubism from their giant cell‐rich histological mimics6
Accounting for intensity variation in image analysis of large‐scale multiplexed clinical trial datasets6
5
Post‐operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and SMAD4 expression5
Low gamma‐butyrobetaine dioxygenase (BBOX1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma: a machine learning approach5
Entropy and expertise: assessing changes in pathologists' language over time using the UK Liver Pathology External Quality Assessment scheme5
Predicting lymph node recurrence in cT1‐2N0 tongue squamous cell carcinoma: collaboration between artificial intelligence and pathologists5
B lymphocytes and tertiary lymphoid structures have a prognostic impact on penile squamous cell carcinoma5
Computational pathology in the age of artificial intelligence – embrace not fear5
5
Assessing the impact of deep‐learning assistance on the histopathological diagnosis of serous tubal intraepithelial carcinoma (STIC) in fallopian tubes5
Explainability and causability in digital pathology5
Molecular subtype concordance and metastatic patterns in muscle‐invasive bladder cancer5
5
The effectiveness of neoadjuvant chemoradiotherapy in oesophageal adenocarcinoma with presence of extracellular mucin, signet‐ring cells, and/or poorly cohesive cells5
Issue Information5
TROP2 in colorectal carcinoma: associations with histopathology, molecular phenotype, and patient prognosis4
ERBB2‐amplified lobular breast carcinoma exhibits concomitant CDK12 co‐amplification associated with poor prognostic features4
Deep learning‐based analysis of EGFR mutation prevalence in lung adenocarcinoma H&E whole slide images4
4
Assessing the association between homologous recombination deficiency scores and treatment response in localized and metastatic prostate cancer4
A membranous nephropathy variant mimicking minimal change disease4
Histopathology‐based assessment of the tumour microenvironment in gastrointestinal cancers: practical approaches to prognostication and treatment stratification4
Contribution of tumour and immune cells to PD‐L1 expression as a predictive biomarker in metastatic triple‐negative breast cancer: exploratory analysis from KEYNOTE‐1194
Mesonephric‐type adenocarcinomas of the ovary: prevalence, diagnostic reproducibility, outcome, and value of PAX24
Synchronous endometrial/cervical and ovarian/fallopian tube carcinoma: a genome‐wide mutation analysis4
Issue Information4
A subset of high‐grade sarcomas with myogenic differentiation are associated with recurrent FGFR fusions3
Subtype‐associated complexity and prognostic significance of the NLRP3 inflammasome landscape in pancreatic neoplasms3
Which descriptor should spread through air spaces (STAS) be incorporated into? T descriptor versus residual tumor classification3
3
Histopathological tumour microenvironment score independently predicts outcome in primary operable colorectal cancer3
AI‐based intra‐tumor heterogeneity score of Ki67 expression as a prognostic marker for early‐stage ER+/HER2− breast cancer3
Reducing the risks of nuclear war – the role of health professionals3
Large multimodal model‐based standardisation of pathology reports with confidence and its prognostic significance3
Issue Information3
Pan‐ TRK expression and NTRK gene aberrations i3
Development of a decision tree diagram for classifying study designs in tumour pathology research: a multidisciplinary approach3
A novel NGS‐based diagnostic algorithm for classifying multifocal lung adenocarcinomas in pN0M0 patients2
The epigenetic modifier lysine methyltransferase 2C is frequently mutated in gastric remnant carcinoma2
Cellular dissociation grading on biopsies of pulmonary squamous cell carcinoma provides prognostic information across all stages and is congruent with resection specimen grading2
Significance of Siglec‐15 expression in colorectal cancer: association with advanced disease stage and fewer tumor‐infiltrating lymphocytes2
Issue Information2
Retrieval‐augmented generation versus document‐grounded generation: a key distinction in large language models2
Expression of B7‐H3 and TIM‐3 in gastric‐type endocervical adenocarcinoma: prevalence, association with PD‐L1 expression, and prognostic significance2
Immunohistochemistry‐based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapy2
The prognostic significance of the IASLC grading system in ALK ‐positive invasive non‐mucinous ade2
Secretory breast carcinoma: morphologic and molecular heterogeneity with indicators of aggressive potential in a cohort of 29 cases2
Dynamic tuft cell expansion during gastric metaplasia and dysplasia2
2
Spatial heterogeneity of antibody–drug conjugate targets in pancreatic ductal adenocarcinoma2
A deep‐learning workflow to predict upper tract urothelial carcinoma protein‐based subtypes from H&E slides supporting the prioritization of patients for molecular testing2
Diagnosing adult and pediatric extrapulmonary tuberculosis by MPT64 antigen detection with immunohistochemistry and immunocytochemistry using reproduced polyclonal antibodies2
Translational milestones in urologic pathology: integrating molecular diagnostics across cancer types2
Enhancing HER2 testing in breast cancer: predicting fluorescence in situ hybridization (FISH) scores from immunohistochemistry images via deep learning2
2
CD70 and PD‐L1 (CD274) co‐expression predicts poor clinical outcomes in patients with pleural mesothelioma2
Development of multiple AI pipelines that predict neoadjuvant chemotherapy response of breast cancer using H&E‐stained tissues2
A quantitative tumor‐wide analysis of morphological heterogeneity of colorectal adenocarcinoma2
0.03656792640686